COVID Rx
Pathogenics Announces Data Demonstrating Novel Anti-Infective/Anti-Inflammatory Medicine Kills COVID-19 Virus
- In Vitro Data Shows NCT Kills SARS-CoV-2 (COVID-19 Virus), Respiratory Syncytial Virus (RSV), and Influenza A Virus
- NCT was Able to Rapidly Kill Viruses Within 1 to 10 Minutes Absent Cytotoxicity of Inactivated NCT
NCT Interview: Anti-COVID Therapies – New Research and Mechanisms of Action
Other
OPKO Health & Pathogenics Announce Data Publication Demonstrating the Potential Utility of NCT in a Severe Eye Infection
- In Vitro Data Shows OPKO’s Formulation of NCT Has Promising Activity Against Acanthamoeba Keratitis, a Serious Ocular Infection
- Provides Additional Evidence That This Phase II Agent Has Good Tolerability and Broad Anti-Microbial Activity Against a Wide Range of Pathogens
Acuity Pharmaceuticals & Pathogenics Announce Preclinical Data Demonstrating Utility of NCT in Viral Conjunctivitis
- New Published Data Show Proprietary Formulation of NCT Has Promising Activity in An Animal Model of This Common Opthalmic Infection That Has No Approved Therapies